256 related articles for article (PubMed ID: 29737253)
1. Febrile Neutropenia in Children with Cancer: Approach to Diagnosis and Treatment.
Kebudi R; Kizilocak H
Curr Pediatr Rev; 2018; 14(3):204-209. PubMed ID: 29737253
[TBL] [Abstract][Full Text] [Related]
2. Third generation cephalosporin resistant Enterobacteriaceae and multidrug resistant gram-negative bacteria causing bacteremia in febrile neutropenia adult cancer patients in Lebanon, broad spectrum antibiotics use as a major risk factor, and correlation with poor prognosis.
Moghnieh R; Estaitieh N; Mugharbil A; Jisr T; Abdallah DI; Ziade F; Sinno L; Ibrahim A
Front Cell Infect Microbiol; 2015; 5():11. PubMed ID: 25729741
[TBL] [Abstract][Full Text] [Related]
3. [Febrile neutropenia in onco-hematology patients hospitalized in Intensive Care Unit].
Saillard C; Sannini A; Chow-Chine L; Blache JL; Brun JP; Mokart D
Bull Cancer; 2015 Apr; 102(4):349-59. PubMed ID: 25799163
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of empiric antibiotic de-escalation in febrile neutropenia.
Kroll AL; Corrigan PA; Patel S; Hawks KG
J Oncol Pharm Pract; 2016 Oct; 22(5):696-701. PubMed ID: 26227319
[TBL] [Abstract][Full Text] [Related]
5. Management of febrile neutropenia in solid organ malignancies following chemotherapy.
Lakshmaiah KC; Abhayakumar SM; Shetty R; Loknath D; Jayashree RS; Govindbabu K
J Cancer Res Ther; 2014; 10(3):540-3. PubMed ID: 25313735
[TBL] [Abstract][Full Text] [Related]
6. Current research in empirical therapy for febrile neutropenia in cancer patients: what should be necessary and what is going on.
Castagnola E; Mikulska M; Barabino P; Lorenzi I; Haupt R; Viscoli C
Expert Opin Emerg Drugs; 2013 Sep; 18(3):263-78. PubMed ID: 23777534
[TBL] [Abstract][Full Text] [Related]
7. Febrile neutropenia: a prospective study to validate the Multinational Association of Supportive Care of Cancer (MASCC) risk-index score.
Uys A; Rapoport BL; Anderson R
Support Care Cancer; 2004 Aug; 12(8):555-60. PubMed ID: 15197637
[TBL] [Abstract][Full Text] [Related]
8. Febrile neutropenic infection occurred in cancer patients undergoing autologous peripheral blood stem cell transplantation.
Zhang WX; Zhao QY; Huang HQ
Transplant Proc; 2015 Mar; 47(2):523-7. PubMed ID: 25769601
[TBL] [Abstract][Full Text] [Related]
9. Tackling antibiotic resistance in febrile neutropenia: current challenges with and recommendations for managing infections with resistant Gram-negative organisms.
Nouér SA; Nucci M; Anaissie E
Expert Rev Hematol; 2015 Oct; 8(5):647-58. PubMed ID: 26115679
[TBL] [Abstract][Full Text] [Related]
10. Ciprofloxacin and amoxicillin as continuation treatment of febrile neutropenia in pediatric cancer patients.
Park JR; Coughlin J; Hawkins D; Friedman DL; Burns JL; Pendergrass T
Med Pediatr Oncol; 2003 Feb; 40(2):93-8. PubMed ID: 12461792
[TBL] [Abstract][Full Text] [Related]
11. Impact of a clinical pathway on appropriate empiric vancomycin use in cancer patients with febrile neutropenia.
Vicente M; Al-Nahedh M; Parsad S; Knoebel RW; Pisano J; Pettit NN
J Oncol Pharm Pract; 2017 Dec; 23(8):575-581. PubMed ID: 27609336
[TBL] [Abstract][Full Text] [Related]
12. [Prevention and treatment of febrile neutropenia].
Montemurro F; Gallicchio M; Aglietta M
Tumori; 1997; 83(2 Suppl):S15-9. PubMed ID: 9235724
[TBL] [Abstract][Full Text] [Related]
13. Empirical oral antibiotic therapy for low risk febrile cancer patients with neutropenia.
Koh A; Pizzo PA
Cancer Invest; 2002; 20(3):420-33. PubMed ID: 12025236
[TBL] [Abstract][Full Text] [Related]
14. Clinical efficacy of cycling empirical antibiotic therapy for febrile neutropenia in pediatric cancer patients.
Teranishi H; Koga Y; Nishio H; Kato W; Ono H; Kanno S; Nakashima K; Takada H
J Infect Chemother; 2017 Jul; 23(7):463-467. PubMed ID: 28527651
[TBL] [Abstract][Full Text] [Related]
15. Randomized comparison of antibiotics with and without granulocyte colony-stimulating factor in children with chemotherapy-induced febrile neutropenia: a report from the Children's Oncology Group.
Ozkaynak MF; Krailo M; Chen Z; Feusner J
Pediatr Blood Cancer; 2005 Sep; 45(3):274-80. PubMed ID: 15806544
[TBL] [Abstract][Full Text] [Related]
16. Empirical antimicrobial treatment for chemotherapy-induced febrile neutropenia.
Bal AM; Gould IM
Int J Antimicrob Agents; 2007 May; 29(5):501-9. PubMed ID: 17346939
[TBL] [Abstract][Full Text] [Related]
17. Adverse effects of antibiotics in children with cancer: are short-course antibiotics for febrile neutropenia part of the solution?
Butters C; Thursky K; Hanna DT; Cole T; Davidson A; Buttery J; Haeusler G
Expert Rev Anti Infect Ther; 2023 Mar; 21(3):267-279. PubMed ID: 36694289
[TBL] [Abstract][Full Text] [Related]
18. Safety of reducing antibiotic use in children with febrile neutropenia: A systematic review.
Moortgat J; Boulanger C; Chatzis O
Pediatr Hematol Oncol; 2022 Nov; 39(8):707-723. PubMed ID: 35465847
[TBL] [Abstract][Full Text] [Related]
19. Antimicrobial prophylaxis and outpatient management of fever and neutropenia in adults treated for malignancy: American Society of Clinical Oncology clinical practice guideline.
Flowers CR; Seidenfeld J; Bow EJ; Karten C; Gleason C; Hawley DK; Kuderer NM; Langston AA; Marr KA; Rolston KV; Ramsey SD
J Clin Oncol; 2013 Feb; 31(6):794-810. PubMed ID: 23319691
[TBL] [Abstract][Full Text] [Related]
20. Febrile Neutropenia: Decreasing Time to Antibiotic Administration in a Community Hospital Emergency Department.
Bruce SD
Clin J Oncol Nurs; 2021 Feb; 25(1):23-26. PubMed ID: 33480869
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
